Loading data for MESO — first visit, this takes a few seconds.

알림

Mesoblast Limited (MESO)

NasdaqGS: MESO · 실시간 가격 · USD

17.02

+1.42 (9.10%)

종가 기준: Aug 18, 2026, 3:59 PM

15.73

-5.64%

프리마켓: 4:00 AM

9.10% (1D)

매수호가	12.35
시가총액	2.16B
매출 (ttm)	65.38M
순이익 (ttm)	-94.37M
베타	0.81
EPS (ttm)	-0.81
P/E (ttm)	n/a
선행 P/E	-277.83
P/B (ttm)	3.74
P/S (ttm)	33.07
Earnings Date	Aug 27, 2026

매도호가	21.82
거래량	451,936
평균 거래량 (20일)	216,803
시가	17.21
전일 종가	15.60
일중 범위	16.84 - 17.48
52주 범위	12.66 - 21.50
애널리스트	n/a
목표주가	n/a
배당	n/a
배당락일	n/a

MESO 소개

Mesoblast Limited, together with its subsidiaries, engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. The company's proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells. It offers Remestemcel-L, which is in Phase III clinical trials for the treatment of systemic inflammatory diseases, including steroid refractor...

[더 보기]

산업 Biotechnology

섹터 Healthcare

IPO 일자 Jan 20, 2010

직원 수 81

상장 거래소 NasdaqGS

티커 MESO

웹사이트 https://www.mesoblast.com

전체 기업 정보

재무 실적

2025년 Mesoblast의 매출은 17.2M로, 전년 5.9M 대비 191.39% 증가했습니다. 순이익은 -102.14M로, 16.13% 증가했습니다.

재무제표

어닝 서프라이즈

Mesoblast가 Aug 30, 2023에 분기 실적을 발표했습니다:

매출 n/a 예상치 하회 $0, 및 NaN% 전년 대비 성장.

EPS -0.29 예상치 상회 0.01, 및 12.12% 전년 대비 성장.

다음 실적 발표

Mesoblast Limited의 실적 발표 예정일은 Aug 27, 2026, 장 마감 후입니다.
애널리스트 예상 매출은 ... 업그레이드

뉴스

2일 전 · MT Newswires

Sector Update: Healthcare Stocks Mixed Monday Afternoon

Healthcare stocks were mixed Monday afternoon, with the NYSE Healthcare Index up nearly 0.1% and the

2일 전 · InvestorsHub

Mesoblast shares jump as Phase 3 chronic back pain trial completes patient treatment

Mesoblast Limited (NASDAQ:MESO) shares rose 9. 5% on Monday after the biotechnology company completed patient treatment in a pivotal Phase 3 study evaluating rexlemestrocel-L for chronic low back pain...

1개월 전 · Zacks

Mesoblast Limited (MESO) is a Great Momentum Stock: Should You Buy?

Does Mesoblast Limited (MESO) have what it takes to be a top stock pick for momentum investors? Let's find out.

1개월 전 · MT Newswires

Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Friday Amid Renewed US-Iran Tensions Ahead of Q2 Earnings Season

The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.03%, and the actively tr

2개월 전 · Simply Wall St.

Kina Securities And 2 Other Stocks That May Be Trading Below Their Estimated Value On The ASX

In the midst of a challenging period for Australian shares, with market sentiment swayed by geopolitical tensions and economic uncertainties, investors are increasingly on the lookout for opportunitie...

2 페이지 중 1

Mesoblast Limited (MESO)